Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Oktober 2007 07:30 ET | Quelle: MIV Therapeutics, Inc.

MIV Therapeutics Announces Live VESTASYNC Follow-Up Case Performed At TCT Conference

ATLANTA, Oct. 23, 2007 (PRIME NEWSWIRE) -- MIV Therapeutics, Inc. (OTCBB:MIVT) (Frankfurt:MIV), a leading developer of next-generation coatings and advanced drug delivery systems for cardiovascular...
31. März 2005 06:00 ET | Quelle: MIV Therapeutics, Inc.

MIV Therapeutics Builds Strength of Drug-Delivery Technologies Program with Appointment of Dr. Dean-Mo Lui as Chief Scientist

VANCOUVER, British Columbia, March 31, 2005 (PRIMEZONE) -- MIV Therapeutics, Inc. (OTCBB:MIVT) a developer of next-generation biocompatible stent coatings and drug delivery technologies, today...
09. September 2004 09:00 ET | Quelle: MIV Therapeutics, Inc.

MIVT Vice President of Coatings, nominated for the 2004 World Technology Award

VANCOUVER, British Columbia, Sept. 9, 2004 (PRIMEZONE) -- MIV Therapeutics Inc. (OTCBB:MIVT) is pleased to announce that Dr. Tom Troczynski, Ph.D., MIVT Vice President of Coatings and Professor of...